Coya Therapeutics

COYANASDAQ
$6.50
0.538.88%
At Close: -
$5.95
-0.55-8.46%
After Hours: Jul 3, 2:44 PM EDT
15 minutes delayed
Coya Therapeutics (COYA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$14.00
Consensus Price Target1
$18.75

want to know what
the Bulls & Bears Say?

Coya Therapeutics (NASDAQ:COYA) Stock, Analyst Ratings, Price Targets, Forecasts

Coya Therapeutics Inc has a consensus price target of $18.75 based on the ratings of 20 analysis. The 3 most-recent analyst ratings were released by Rodman & Renshaw, Chardan Capital, and Chardan Capital on June 13, 2024, June 5, 2024, and May 9, 2024, respectively. With an average price target of $15.33 between Rodman & Renshaw, Chardan Capital, and Chardan Capital, there's an implied 157.70% upside for Coya Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Rodman & Renshaw
Chardan Capital
EF Hutton
BTIG

1calculated from analyst ratings

Analyst Ratings for Coya Therapeutics

Buy NowGet Alert
06/13/2024Buy Now202.52%Rodman & Renshaw
Elemer Piros
 → $18Initiates → BuyGet Alert
06/05/2024Buy Now135.29%Chardan Capital
Keay Nakae
$14 → $14MaintainsBuyGet Alert
05/09/2024Buy Now135.29%Chardan Capital
Keay Nakae
$14 → $14MaintainsBuyGet Alert
04/29/2024Buy Now135.29%Chardan Capital
Keay Nakae
$14 → $14MaintainsBuyGet Alert
03/20/2024Buy Now135.29%Chardan Capital
Keay Nakae
$11 → $14MaintainsBuyGet Alert
08/09/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28ReiteratesBuy → BuyGet Alert
08/09/2023Buy Now84.87%Chardan Capital
Keay Nakae
 → $11ReiteratesBuy → BuyGet Alert
07/18/2023Buy Now84.87%Chardan Capital
Keay Nakae
 → $11ReiteratesBuy → BuyGet Alert
07/18/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28ReiteratesBuy → BuyGet Alert
07/17/2023Buy Now84.87%Chardan Capital
Keay Nakae
$11 → $11ReiteratesBuy → BuyGet Alert
06/08/2023Buy Now84.87%Chardan Capital
Keay Nakae
$9 → $11MaintainsBuyGet Alert
06/07/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28ReiteratesBuy → BuyGet Alert
05/18/2023Buy Now152.1%BTIG
Thomas Shrader
 → $15Initiates → BuyGet Alert
05/17/2023Buy Now51.26%Chardan Capital
Keay Nakae
 → $9ReiteratesBuy → BuyGet Alert
05/16/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28ReiteratesBuy → BuyGet Alert
05/10/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28ReiteratesBuy → BuyGet Alert
05/03/2023Buy Now370.59%EF Hutton
Elemer Piros
 → $28Initiates → BuyGet Alert
03/30/2023Buy Now51.26%Chardan Capital
Keay Nakae
 → $9Reiterates → BuyGet Alert
03/22/2023Buy Now51.26%Chardan Capital
Keay Nakae
 → $9Reiterates → BuyGet Alert
01/26/2023Buy Now51.26%Chardan Capital
Keay Nakae
 → $9Initiates → BuyGet Alert

FAQ

Q

What is the target price for Coya Therapeutics (COYA) stock?

A

The latest price target for Coya Therapeutics (NASDAQ:COYA) was reported by Rodman & Renshaw on June 13, 2024. The analyst firm set a price target for $18.00 expecting COYA to rise to within 12 months (a possible 202.52% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Coya Therapeutics (COYA)?

A

The latest analyst rating for Coya Therapeutics (NASDAQ:COYA) was provided by Rodman & Renshaw, and Coya Therapeutics initiated their buy rating.

Q

When was the last upgrade for Coya Therapeutics (COYA)?

A

There is no last upgrade for Coya Therapeutics

Q

When was the last downgrade for Coya Therapeutics (COYA)?

A

There is no last downgrade for Coya Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Coya Therapeutics (COYA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on June 13, 2024 so you should expect the next rating to be made available sometime around June 13, 2025.

Q

Is the Analyst Rating Coya Therapeutics (COYA) correct?

A

While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a initiated with a price target of $0.00 to $18.00. The current price Coya Therapeutics (COYA) is trading at is $5.95, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch